Payment overview · 2025
General Payments
$245.19
2 reported records · 2 companies
Healthcare provider profile · identity verified
Emily Moon, APNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · MILWAUKEE, WI · NPI 1891349858
Verified facts
What the public records show
CMS Open Payments records show Emily Moon, APNP received $245.19 in general payments during 2025 across 2 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 50.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $124.50 | 50.8% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $120.69 | 49.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $245.19 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $124.50 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $120.69 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 641 | 68 |
| Atorvastatin Calcium | Atorvastatin Calcium | 615 | 70 |
| Levothyroxine Sodium | Levothyroxine Sodium | 513 | 55 |
| Amlodipine Besylate | Amlodipine Besylate | 486 | 58 |
| Sertraline Hcl | Sertraline Hcl | 465 | 54 |
| Lisinopril | Lisinopril | 451 | 50 |
| Eliquis | Apixaban | 421 | 43 |
| Losartan Potassium | Losartan Potassium | 357 | 42 |
| Gabapentin | Gabapentin | 295 | 35 |
| Quetiapine Fumarate | Quetiapine Fumarate | 283 | 36 |
| Warfarin Sodium | Warfarin Sodium | 263 | 15 |
| Metoprolol Succinate | Metoprolol Succinate | 256 | 31 |
| Donepezil Hcl | Donepezil Hcl | 242 | 28 |
| Omeprazole | Omeprazole | 241 | 30 |
| Potassium Chloride | Potassium Chloride | 234 | 31 |
| Mirtazapine | Mirtazapine | 223 | 25 |
| Famotidine | Famotidine | 220 | 22 |
| Pantoprazole Sodium | Pantoprazole Sodium | 217 | 33 |
| Risperidone | Risperidone | 213 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 201 | 26 |
| Metformin Hcl Er | Metformin Hcl | 196 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 188 | 23 |
| Metformin Hcl | Metformin Hcl | 187 | 22 |
| Memantine Hcl | Memantine Hcl | 186 | 20 |
| Loperamide | Loperamide Hcl | 175 | 70 |
| Escitalopram Oxalate | Escitalopram Oxalate | 172 | 20 |
| Jardiance | Empagliflozin | 159 | 17 |
| Trazodone Hcl | Trazodone Hcl | 156 | 25 |
| Buspirone Hcl | Buspirone Hcl | 141 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 125 | 15 |
| Glipizide | Glipizide | 122 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 118 | 13 |
| Carvedilol | Carvedilol | 117 | 13 |
| Simvastatin | Simvastatin | 116 | 15 |
| Allopurinol | Allopurinol | 114 | 15 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 113 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 107 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 105 | 15 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 101 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 100 | 12 |
| Nystop | Nystatin | 99 | 32 |
| Tramadol Hcl | Tramadol Hcl | 93 | 19 |
| Pregabalin | Pregabalin | 88 | suppressed |
| Latanoprost | Latanoprost | 83 | 12 |
| Olanzapine | Olanzapine | 80 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 79 | 19 |
| Lorazepam | Lorazepam | 76 | 17 |
| Nystatin | Nystatin | 76 | 28 |
| Myrbetriq | Mirabegron | 74 | suppressed |
| Levetiracetam | Levetiracetam | 72 | suppressed |
| Lovastatin | Lovastatin | 72 | suppressed |
| Baclofen | Baclofen | 68 | suppressed |
| Spironolactone | Spironolactone | 68 | suppressed |
| Aripiprazole | Aripiprazole | 67 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 62 | suppressed |
| Meloxicam | Meloxicam | 62 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 60 | suppressed |
| Bupropion Xl | Bupropion Hcl | 59 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 56 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 55 | suppressed |
| Ondansetron Odt | Ondansetron | 48 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 48 | suppressed |
| Bumetanide | Bumetanide | 46 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | suppressed |
| Ezetimibe | Ezetimibe | 45 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 45 | suppressed |
| Cephalexin | Cephalexin | 44 | 35 |
| Amiodarone Hcl | Amiodarone Hcl | 43 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 42 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 38 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 38 | suppressed |
| Januvia | Sitagliptin Phosphate | 38 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 37 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | suppressed |
| Methotrexate | Methotrexate Sodium | 37 | suppressed |
| Sucralfate | Sucralfate | 37 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 36 | suppressed |
| Finasteride | Finasteride | 35 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 34 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 33 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 33 | suppressed |
| Primidone | Primidone | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Lamotrigine | Lamotrigine | 29 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 27 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 27 | suppressed |
| Timolol Maleate | Timolol Maleate | 27 | suppressed |
| Torsemide | Torsemide | 27 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 26 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 26 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Atenolol | Atenolol | 23 | suppressed |
| Linzess | Linaclotide | 23 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 22 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 21 | suppressed |
| Prednisone | Prednisone | 21 | 13 |
| Rivastigmine | Rivastigmine Tartrate | 21 | suppressed |
| Desloratadine | Desloratadine | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 20 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 20 | 20 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 17 |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Nyamyc | Nystatin | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Cefdinir | Cefdinir | 18 | suppressed |
| Metolazone | Metolazone | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Alprazolam | Alprazolam | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Erythromycin | Erythromycin Base | 14 | 12 |
| Haloperidol | Haloperidol | 14 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Mirabegron Er | Mirabegron | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Niacin Er | Niacin | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 12 | 12 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Calcitriol | Calcitriol | 11 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $245.19 · 2 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error